Loading clinical trials...
Loading clinical trials...
This is a Phase II, multi-center, randomized, double-blind study comparing the safety and efficacy of two doses of BC-3781 versus vancomycin in patients with acute bacterial skin and skin structure in...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Nabriva Therapeutics AG
NCT00018044 · Mycobacterium Infections
NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more
NCT07537634 · Helicobacter Pylori Infection, Dyspepsia, and more
NCT00344188 · Leishmaniasis, Skin Diseases, Parasitic, and more
NCT07286370 · Salmonella Infections
BC-3781 Study Center 002
Chula Vista, California
BC-3781 Study Center 001
La Mesa, California
BC-3781 Study Center 003
Oceanside, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions